What Are Anxiety Disorders? Types, Symptoms, Causes, and When to Seek Help

Anxiety disorders are a group of mental health conditions defined by persistent, excessive fear or worry that is disproportionate to any actual threat, difficult to control, and severe enough to interfere with daily functioning. They are the most prevalent class of mental health disorders in the United States: approximately 19.1% of U.S. adults — nearly one in five — meet diagnostic criteria for an anxiety disorder in any given year, and 31.1% will experience one at some point in their lives (National Institute of Mental Health [NIMH], 2023).

Anxiety disorders differ from normal anxiety — the adaptive stress response that sharpens attention before a difficult task or signals genuine danger — in two key ways: the fear or worry is out of proportion to the actual situation, and it does not resolve when the triggering situation passes. The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition — the standard clinical reference for psychiatric diagnosis) requires that symptoms persist for a minimum duration (at least six months for most disorders) and cause clinically significant distress or functional impairment before a diagnosis is made (American Psychiatric Association, 2022).

KEY HIGHLIGHTS

• Prevalence and gender gap: 19.1% of U.S. adults experienced an anxiety disorder in the past year. Prevalence is significantly higher in females (23.4%) than in males (14.3%), and 31.9% of adolescents ages 13–18 have a lifetime anxiety disorder diagnosis (NIMH, 2023).
• Most common mental health condition globally: The World Health Organization estimates that anxiety disorders affect approximately 301 million people worldwide — more than any other mental health condition — making them the leading cause of disability in the category of mental disorders (WHO, 2023).
• Severe treatment gap: Despite being highly treatable, only an estimated 36.9% of people with anxiety disorders receive any treatment. Barriers include stigma, cost, provider shortages, and lack of recognition that symptoms constitute a diagnosable condition (NIMH, 2023).
• Five major anxiety disorder types: The DSM-5 classifies anxiety disorders into five primary diagnoses — generalized anxiety disorder (GAD), panic disorder, social anxiety disorder (SAD), specific phobias, and agoraphobia — each with distinct triggers, symptom profiles, and treatment approaches.
• Neurobiological basis confirmed: A 2024 systematic review published in Translational Psychiatry confirmed that anxiety disorders involve measurable dysregulation in the brain’s fear circuitry — specifically, reduced GABA-A and serotonin receptor binding in the amygdala — alongside disruption of the hypothalamic-pituitary-adrenal (HPA) axis stress-response system (Mochcovitch et al., 2024).
• CBT remains gold-standard — and holds up: A 2025 meta-analysis of 49 randomized controlled trials (3,645 participants) published in Clinical Psychology Review confirmed that CBT (cognitive behavioral therapy) produces consistent, clinically meaningful effects for anxiety disorders across all disorder types, with moderate-to-large effect sizes sustained over 30 years of study (Hofmann et al., 2025).
• High comorbidity burden: More than 50% of people with a primary anxiety disorder also meet criteria for at least one other condition — most commonly major depressive disorder — and individuals with co-occurring depression and anxiety have worse outcomes and higher healthcare costs if either condition is treated in isolation (NIMH, 2023).

What Are Anxiety Disorders?

Anxiety disorders are a clinically distinct category of mental health conditions characterized by dysregulated fear and anxiety responses that are excessive relative to any genuine threat, persistent rather than transient, and functionally impairing. The DSM-5 separates anxiety disorders from closely related conditions — including obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) — which were previously grouped under the anxiety disorders umbrella but now occupy their own categories in the diagnostic manual (American Psychiatric Association, 2022).

The distinction between fear and anxiety is clinically important. Fear is the emotional response to a real or perceived immediate threat — it is adaptive, prepares the body to respond, and dissipates when the threat passes. Anxiety is anticipatory: it is oriented toward future possible threats, is often diffuse rather than attached to a specific object, and persists even in the absence of danger. Both fear and anxiety activate overlapping neural circuits, but chronic anxiety involves a sustained over-activation of those circuits that produces lasting disruption to mood, cognition, physical health, and behavior.

Anxiety disorders share a core mechanism: the brain’s threat-detection system — anchored in the amygdala (the brain’s alarm center) and its connections to the prefrontal cortex (the decision-making and regulation center) — becomes persistently over-reactive, triggering fear responses in situations that most people would not find threatening. This over-reactivity is not a choice or character weakness; it reflects measurable neurobiological differences in brain circuit function and neurochemistry (Mochcovitch et al., 2024).

What Are the Different Types of Anxiety Disorders?

The five major types of anxiety disorders recognized in the DSM-5 are generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobias, and agoraphobia. Each is defined by a distinct triggering pattern, required symptom duration, and evidence-based treatment approach. The table below summarizes key clinical features for each:

Disorder	Core Fear / Trigger	Min. Duration	U.S. Prevalence	First-Line Treatment
Generalized Anxiety Disorder (GAD)	Excessive, uncontrollable worry about multiple everyday topics	6 months	3.1% past year; 5.7% lifetime	CBT; SSRIs or SNRIs; buspirone
Panic Disorder	Recurrent unexpected panic attacks + ongoing fear of future attacks	1 month of persistent concern post-attack	1.6–4% lifetime	CBT with interoceptive exposure; SSRIs
Social Anxiety Disorder (SAD)	Fear of social scrutiny, embarrassment, or humiliation in social situations	6 months	7.1% past year; 13% lifetime	Individual or group CBT; SSRIs; beta-blockers for performance subtype
Specific Phobia	Intense fear of a specific object or situation (e.g., heights, blood, flying)	6 months	~9.1% past year	Exposure-based CBT (single-session protocols effective for some phobia types)
Agoraphobia	Fear of situations where escape is difficult or help unavailable during panic-like symptoms	6 months	~1.7% past year	CBT; SSRIs; combined treatment if severe

Two additional conditions — separation anxiety disorder (persistent, excessive fear of separation from an attachment figure, now recognized in adults as well as children) and selective mutism (consistent failure to speak in specific social situations despite speaking in others, primarily in children) — round out the DSM-5 anxiety disorder category. Separation anxiety disorder has a lifetime adult prevalence of approximately 6.6%, though it is widely underdiagnosed in adult populations (NIMH, 2023).

What Are the Symptoms of Anxiety Disorders?

The symptoms of anxiety disorders span three overlapping categories — emotional and cognitive, physical, and behavioral — and vary in specific presentation depending on disorder type. The common thread across all anxiety disorders is that the symptoms are persistent, distressing, and cause meaningful interference with daily life.

Emotional and cognitive symptoms include persistent, uncontrollable worry; anticipatory dread; racing or intrusive thoughts; difficulty concentrating; irritability; a sense of impending doom; and in social anxiety disorder specifically, intense preoccupation with being negatively evaluated by others. In panic disorder, a hallmark cognitive feature is “fear of fear” — the anxious expectation of another panic attack — which itself sustains the disorder after the initial episode.

Physical symptoms arise from activation of the autonomic nervous system (the body’s automatic stress response) and include increased heart rate (palpitations), shortness of breath, chest tightness, muscle tension, trembling, sweating, nausea, dizziness, dry mouth, and gastrointestinal disturbance. These physical symptoms are real and physiologically measurable; they are not imagined. In panic disorder, physical symptoms are intense and acute, often resembling cardiac events closely enough that many people with undiagnosed panic disorder present first to emergency departments.

Behavioral symptoms center on avoidance — the most functionally impairing feature of anxiety disorders. Individuals avoid situations, people, places, or activities associated with feared outcomes. While avoidance reduces distress in the short term, it maintains the anxiety disorder long-term by preventing the person from learning that the feared situation is manageable or that the feared outcome is unlikely. Avoidance is also the primary mechanism that converts a phobia or social anxiety problem into a progressively smaller and more restricted life. Safety behaviors — such as always having an exit route, never making eye contact, or carrying medications “just in case” — serve a similar function to avoidance and similarly maintain the disorder.

What Causes Anxiety Disorders?

The causes of anxiety disorders are multifactorial, arising from an interaction between genetic vulnerability, neurobiological differences, early life experiences, and ongoing environmental stressors. No single cause explains anxiety disorders, and the relative contribution of each factor varies significantly between individuals and between disorder types.

Neurobiological factors: Anxiety disorders are rooted in dysregulation of the brain’s fear circuitry. The amygdala — which detects and responds to potential threats — shows hyperactivation in people with anxiety disorders, while the prefrontal cortex — which regulates emotional responses and provides contextual judgment — shows reduced inhibitory control over the amygdala. The result is a brain that generates strong fear responses to non-threatening stimuli and struggles to down-regulate them effectively. Neurochemically, reduced binding of GABA-A receptors (GABA is the brain’s primary inhibitory neurotransmitter — it reduces neural firing and produces calm) and dysregulated serotonin signaling in the amygdala are consistently implicated across anxiety disorder types (Mochcovitch et al., 2024). The HPA (hypothalamic-pituitary-adrenal) axis — the brain-body stress hormone system — also shows dysregulation in anxiety disorders; a 2025 review in Current Psychiatry Reports confirmed that disrupted cortisol dynamics within the HPA axis contribute to the hyperarousal and hypervigilance characteristic of anxiety disorders (Bounoua et al., 2025).

Genetic factors: Anxiety disorders run in families. Heritability estimates range from approximately 30% for specific phobias to 40–50% for panic disorder and GAD. Twin studies confirm that genetic factors account for a meaningful proportion of liability — but genes are not destiny. Having a genetic predisposition increases risk; it does not guarantee the development of a disorder. Environmental factors determine whether and how that predisposition is expressed.

Environmental and developmental factors: Adverse childhood experiences (ACEs) — including abuse, neglect, witnessing family violence, and chronic unpredictability — are among the strongest environmental predictors of anxiety disorder onset. Traumatic events at any age can trigger acute anxiety that develops into a chronic disorder. Chronic stress, social isolation, and major life transitions (job loss, bereavement, relationship breakdown) also significantly elevate risk. Crucially, environmental stressors and genetic vulnerability interact: individuals with genetic risk for anxiety are significantly more reactive to environmental stressors than those without that genetic background.

How Are Anxiety Disorders Diagnosed?

Anxiety disorders are diagnosed through a structured clinical evaluation comparing a person’s symptom history against DSM-5 diagnostic criteria. There is no blood test, brain scan, or biological marker that independently confirms an anxiety disorder diagnosis. Instead, a licensed mental health professional or physician evaluates the pattern of symptoms, their duration, their triggers, and their impact on daily functioning.

A thorough assessment also rules out medical conditions that can produce anxiety-like symptoms — including thyroid disorders (hyperthyroidism frequently produces palpitations, tremor, and anxiety), cardiac arrhythmias, hypoglycemia (low blood sugar), and stimulant or substance use. A complete evaluation includes a medical history, current medication review, substance use history, family psychiatric history, and standardized screening instruments such as the GAD-7 (Generalized Anxiety Disorder 7-item scale — a validated, seven-question self-report measure that quantifies anxiety severity) and the PHQ-4 (a four-item combined screen for depression and anxiety).

Co-occurring conditions must be identified during assessment. Because more than 50% of people with an anxiety disorder also experience depression, and because many people meet criteria for more than one anxiety disorder simultaneously, a comprehensive evaluation addresses the full clinical picture rather than a single presenting problem. Treating anxiety without identifying co-occurring depression, for example, substantially reduces treatment success rates.

What Treatments Are Available for Anxiety Disorders?

The treatments available for anxiety disorders are evidence-based and effective across all major disorder types. First-line treatment involves either cognitive behavioral therapy (CBT), medication, or a combination of the two — with CBT generally recommended as the preferred first-line approach due to its durability, minimal side effects, and skill-building component.

Cognitive behavioral therapy (CBT): CBT is a structured, time-limited psychotherapy that helps individuals identify and change the thought patterns and avoidance behaviors that maintain anxiety. The exposure component of CBT — systematically confronting feared situations in a controlled way, with the support of a therapist — is consistently the most effective element of treatment. A landmark 2025 meta-analysis pooling 49 randomized controlled trials and 3,645 participants confirmed that CBT produces consistent and clinically meaningful symptom reductions across all anxiety disorder types, with the moderate-to-large effect sizes holding stable across 30 years of randomized trial data (Hofmann et al., 2025). Individual CBT formats outperform group formats for social anxiety disorder and PTSD specifically.

Medications: The two primary medication classes used to treat anxiety disorders are SSRIs (selective serotonin reuptake inhibitors — medications that increase serotonin availability in the brain, such as sertraline and escitalopram) and SNRIs (serotonin-norepinephrine reuptake inhibitors, such as venlafaxine). Both classes are FDA-approved for multiple anxiety disorder types, typically require two to four weeks before full therapeutic effect is reached, and are most effective when combined with psychotherapy. Buspirone is an alternative anti-anxiety medication used primarily for GAD. Benzodiazepines (such as lorazepam and alprazolam) produce rapid symptom relief but carry risks of dependence and are generally recommended only for short-term use or crisis management rather than long-term anxiety treatment.

Emerging and adjunctive approaches: Virtual reality exposure therapy — in which a person is immersed in computer-generated feared environments through a headset — has demonstrated efficacy comparable to traditional in-person exposure therapy for specific phobias and social anxiety disorder, expanding access to exposure-based treatment. Mindfulness-based cognitive therapy (MBCT) has a robust evidence base as a relapse prevention approach for people who have responded to initial treatment. Exercise has demonstrated moderate efficacy as an adjunct to standard care: regular aerobic activity reduces HPA axis reactivity and has been shown in multiple randomized trials to produce anxiety symptom reductions equivalent to those of medication in mild-to-moderate presentations.

When Should You Seek Help for Anxiety?

You should seek professional evaluation when anxiety symptoms are persistent (lasting more than several weeks), cause meaningful disruption to daily functioning, or involve any of the following clinical indicators:

• Avoidance that is narrowing your life: If anxiety has caused you to stop doing things that were previously normal — attending work, socializing, traveling, or engaging in activities you once enjoyed — this is a clear indicator that it has crossed into clinical territory requiring assessment.
• Physical symptoms without a medical explanation: Frequent chest tightness, palpitations, shortness of breath, stomach problems, or persistent muscle tension that a physician cannot attribute to a physical cause warrant evaluation for an anxiety disorder, particularly panic disorder or GAD.
• Sleep disruption: Chronic difficulty falling or staying asleep — especially when driven by racing thoughts, worry, or anticipatory dread — is strongly associated with anxiety disorders and significantly worsens long-term outcomes when untreated.
• Symptoms persisting for six or more weeks: Occasional anxiety after a stressful event is expected. When excessive fear or worry continues well beyond the triggering circumstances, or arises without a clear cause, a structured clinical evaluation is warranted to determine whether a diagnosable condition is present.
• Co-occurring low mood or substance use: Using alcohol or substances to manage anxiety, or experiencing persistent low mood alongside anxiety, significantly increases the complexity of the condition and the need for comprehensive professional assessment — not just self-management strategies.

The first step is speaking with a primary care physician who can rule out medical causes and provide a referral, or directly scheduling an evaluation with a licensed mental health professional — such as a psychologist, licensed clinical social worker (LCSW), or psychiatrist — who specializes in anxiety disorders. Free online screening tools such as the ADAA’s anxiety screening at adaa.org provide a useful first step for individuals uncertain whether their symptoms warrant formal evaluation.

WHAT TO DO NEXT

Anxiety disorders are among the most well-understood and effectively treated conditions in all of medicine. The combination of CBT and, where indicated, medication produces meaningful and durable symptom reduction for the large majority of people who receive appropriate care. The most consequential barrier to recovery is delay: on average, people with anxiety disorders wait more than 11 years between the onset of symptoms and receiving any treatment (NIMH, 2023).

If you recognize these symptoms in yourself or someone you care about, speak with a primary care provider or licensed mental health professional who can conduct a structured assessment and, if warranted, connect you with appropriate evidence-based care. If you are in crisis, call or text 988 — the Suicide and Crisis Lifeline — available 24 hours a day, 7 days a week, free and confidential.

REFERENCES

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787

Bounoua, N., Michopoulos, V., & Gillespie, C. F. (2025). Influence of the HPA axis on anxiety-related processes: An RDoC overview considering their neural correlates. Current Psychiatry Reports. https://doi.org/10.1007/s11920-025-01633-5

Carpenter, J. K., Andrews, L. A., Witcraft, S. M., Powers, M. B., Smits, J. A. J., & Hofmann, S. G. (2018). Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depression and Anxiety, 35(6), 502–514. https://doi.org/10.1002/da.22728

Hofmann, S. G., Kasch, C., & Reis, A. (2025). Effect sizes of randomized-controlled studies of cognitive behavioral therapy for anxiety disorders over the past 30 years. Clinical Psychology Review, 117, 102553. https://doi.org/10.1016/j.cpr.2025.102553

Mochcovitch, M. D., Freire, R. C. R., Garcia, R. F., & Nardi, A. E. (2024). Neurochemical and genetic factors in panic disorder: A systematic review. Translational Psychiatry, 14, 315. https://doi.org/10.1038/s41398-024-02966-0

National Institute of Mental Health. (2023). Any anxiety disorder. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder

National Institute of Mental Health. (2023). Anxiety disorders. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/anxiety-disorders

National Institute of Mental Health. (2023). Generalized anxiety disorder: What you need to know. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad

National Institute of Mental Health. (2023). Panic disorder: When fear overwhelms. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/panic-disorder-when-fear-overwhelms

National Institute of Mental Health. (2023). Social anxiety disorder: More than just shyness. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/social-anxiety-disorder-more-than-just-shyness

World Health Organization. (2023). Mental disorders: Key facts. https://www.who.int/news-room/fact-sheets/detail/mental-disorders